Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell of proximal tubule | 5 studies | 48% ± 21% | |
| kidney loop of Henle epithelial cell | 5 studies | 38% ± 11% | |
| astrocyte | 5 studies | 40% ± 16% | |
| parietal epithelial cell | 4 studies | 65% ± 18% | |
| renal alpha-intercalated cell | 4 studies | 49% ± 17% | |
| renal principal cell | 4 studies | 74% ± 12% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 54% ± 8% | |
| epithelial cell | 3 studies | 56% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| kidney | 4 studies | 44% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 29088.02 | 89 / 89 | 94% | 81.44 | 851 / 901 |
| thymus | 100% | 100488.36 | 653 / 653 | 85% | 302.55 | 514 / 605 |
| ovary | 83% | 258.77 | 150 / 180 | 97% | 162.70 | 415 / 430 |
| uterus | 81% | 636.07 | 137 / 170 | 22% | 21.20 | 100 / 459 |
| adrenal gland | 100% | 735.72 | 258 / 258 | 0% | 0 | 0 / 230 |
| lung | 93% | 216.49 | 535 / 578 | 0% | 0.48 | 4 / 1155 |
| skin | 92% | 224.30 | 1668 / 1809 | 0% | 0.13 | 2 / 472 |
| adipose | 91% | 275.95 | 1093 / 1204 | 0% | 0 | 0 / 0 |
| breast | 88% | 238.73 | 402 / 459 | 0% | 0 | 0 / 1118 |
| intestine | 86% | 201.54 | 829 / 966 | 1% | 0.12 | 3 / 527 |
| stomach | 85% | 130.29 | 304 / 359 | 0% | 0.06 | 1 / 286 |
| bladder | 81% | 94.67 | 17 / 21 | 3% | 1.64 | 17 / 504 |
| esophagus | 82% | 168.04 | 1192 / 1445 | 1% | 0.10 | 1 / 183 |
| liver | 79% | 92.29 | 178 / 226 | 1% | 0.20 | 3 / 406 |
| prostate | 78% | 175.33 | 191 / 245 | 0% | 0.07 | 1 / 502 |
| spleen | 78% | 116.09 | 188 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 71% | 95.57 | 943 / 1335 | 0% | 0 | 0 / 0 |
| brain | 62% | 95.57 | 1650 / 2642 | 0% | 0 | 0 / 705 |
| heart | 60% | 60.85 | 514 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 54% | 70.63 | 176 / 328 | 1% | 0.14 | 1 / 178 |
| peripheral blood | 47% | 59.28 | 441 / 929 | 0% | 0 | 0 / 0 |
| muscle | 27% | 29.36 | 219 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
| GO_0071371 | Biological process | cellular response to gonadotropin stimulus |
| GO_2000611 | Biological process | positive regulation of thyroid hormone generation |
| GO_1900218 | Biological process | negative regulation of apoptotic process involved in metanephric nephron tubule development |
| GO_0001655 | Biological process | urogenital system development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_2000594 | Biological process | positive regulation of metanephric DCT cell differentiation |
| GO_0072284 | Biological process | metanephric S-shaped body morphogenesis |
| GO_0072221 | Biological process | metanephric distal convoluted tubule development |
| GO_0001822 | Biological process | kidney development |
| GO_0030878 | Biological process | thyroid gland development |
| GO_0038194 | Biological process | thyroid-stimulating hormone signaling pathway |
| GO_0003281 | Biological process | ventricular septum development |
| GO_0072207 | Biological process | metanephric epithelium development |
| GO_2000612 | Biological process | regulation of thyroid-stimulating hormone secretion |
| GO_0072305 | Biological process | negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis |
| GO_0006351 | Biological process | DNA-templated transcription |
| GO_0001823 | Biological process | mesonephros development |
| GO_0072108 | Biological process | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0072307 | Biological process | regulation of metanephric nephron tubule epithelial cell differentiation |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0072289 | Biological process | metanephric nephron tubule formation |
| GO_1900212 | Biological process | negative regulation of mesenchymal cell apoptotic process involved in metanephros development |
| GO_0048793 | Biological process | pronephros development |
| GO_0039003 | Biological process | pronephric field specification |
| GO_0072278 | Biological process | metanephric comma-shaped body morphogenesis |
| GO_1900215 | Biological process | negative regulation of apoptotic process involved in metanephric collecting duct development |
| GO_0090190 | Biological process | positive regulation of branching involved in ureteric bud morphogenesis |
| GO_0009653 | Biological process | anatomical structure morphogenesis |
| GO_0007417 | Biological process | central nervous system development |
| GO_0042472 | Biological process | inner ear morphogenesis |
| GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
| GO_0048856 | Biological process | anatomical structure development |
| GO_0006790 | Biological process | sulfur compound metabolic process |
| GO_0003337 | Biological process | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0071599 | Biological process | otic vesicle development |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0000976 | Molecular function | transcription cis-regulatory region binding |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0004996 | Molecular function | thyroid-stimulating hormone receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PAX8 |
| Protein name | Paired box protein Pax-8 Paired box 8 |
| Synonyms | hCG_26667 |
| Description | FUNCTION: Transcription factor for the thyroid-specific expression of the genes exclusively expressed in the thyroid cell type, maintaining the functional differentiation of such cells. |
| Accessions | ENST00000397647.7 [Q06710-5] ENST00000348715.9 [Q06710-3] ENST00000554830.2 H0YJZ5 A0A0S2Z4P2 ENST00000497038.6 ENST00000465084.1 R9W7C9 A0A7P0T907 ENST00000468980.4 ENST00000468980.4 [Q06710-2] A0A024R531 ENST00000263334.9 [Q06710-1] ENST00000263335.11 [Q06710-4] ENST00000429538.8 [Q06710-1] Q06710 H0YJD1 A0A140TA56 G3V3F3 ENST00000681162.1 |
